usa, page-5

Trouble with IMI, BH, is that they have 1.2 billion shares on issue and a product that is not disposable. Once you have the product, you have it, unlike SBN where you need a new one every time you test. The costs and the growth potential just don't stack up. It is only my opinion, without a lot of in depth research, but I only do one share at a time.